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The result ofthe clinical trial using the lung imaging fluorescence endoscope (LIFE) was
reported. A total of 77 biopsy confirmed sites from 30 patients were evaluated. The
sensitivity for metaplasia detection by the LIFE system was 96% compared to 28% by
conventional bronchoscopy. The LIFE system was found to be useful in detecting subtle
cancerous/precancerous lesions.
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INTRODUCTION
The increasing numbers of lung cancer deaths
throughout the world are mainly due to the detection
of the disease at late stage. Since lung cancer is highly
malignant, its prevention and early detection are
essential to decrease the death rate. However, the
detection of early lung cancer, especially carcinoma in
situ, is a diagnostic challenge for bronchoscopists
because these lesions do not always show
endoscopically visible changes [1]. Photodynamic
diagnosis is a modality to enhance the lesions using
photosensitizer which has an affinity to tumor
tissue [2-4]. However, photosensitizers can have side
effects and are not commonly used. To overcome this
problem, fluorescence detection system has been
created. The lung imaging fluorescence endoscope
(LIFE) system was developed to detect precancerous
and CIS lesions, based on differences in normal and
abnormal tissue auto-fluorescence [5-7]. In this study,
the authors will report the result ofa clinical trial using
the LIFE system performed at our institution.
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Table Histological classification of
the biopsied sites
(77 sites 30 cases)
Invasive cancer
Carcinoma in situ
Squamous metaplasia
Normal/Inflammation
13 sites
3 sites
25 sites
36 sites
metaplasia 25, normal and chronic inflammation 36,
respectively. These cases were referred to Tokyo
Medical College Hospital because ofa strong suspicion
of lung cancer or abnormal sputum cytology findings.
The number of examinations using the LIFE system
were restricted to thirty per institution in this clinical
trial by the Japanese Ministry of Health and Welfare.
Table II Endoscopy and biopsy results.
BF
LIFE
negative
positive
negative positive
Carcinoma in situ (3 sites)
MATERIAL AND METHOD
Lung Imaging Fluorescence Endoscope (LIFE)[5]
Normal bronchial tissue fluoresces green when excited
by blue light, but abnormal tissue lacks green
auto-fluorescence [8,9]. Sophisticated application of
this principle produced the LIFE system [8]. The LIFE
system consists of a light source (helium-cadmium
laser, 442 nm) and image intensifier (CCD camera
with green and red filters). Two images at different
(red and green) wavelengths are simultaneously
captured. The images are combined and processed by
an imaging board using a special algorithm that
separates images of normal tissue from those from
cancerous/precancerous tissue. The autofluorescence
image is displayed in real time on image monitor.
Clinical Protocol
Conventional fiberoptic bronchoscopic examination
(BF 20 or BF 1T-30, Olympus Optical Co., Tokyo,
Japan) was first performed and areas with abnormal
findings (suspicious for cancer or metaplasia) were
noted for subsequent biopsy. The fluorescence
examination was performed. Any abnormal areas
recognized by conventional bronchoscopy or by the
LIFE system were biopsied. Procedures were carded
out under local anesthesia and no additional sedation
was needed in any case nor was there any complaint
of side effects. All biopsy specimens were interpreted
in our Department of Pathology, and pathological
diagnosis was the gold standard for the comparison of
diagnostic accuracy ofconventional bronchoscopy and
LIFE.
Subjects
A total of 30 subjects were studied and 77 sites were
biopsied. Table I shows the histological result of the
biopsies: invasive cancer 13, CIS 3, atypical squamous
FIGURE 1A Right B6 under conventional bronchoscopy.
Thickening of bifurcation was found.EARLY LOCALIZATION OF BRONCHOGENIC CANCEROUS LESIONS WITH LIFE 199
FIGURE IB Same area as Figure la under LIFE examination.
Carcinoma in situ appeared cold image.
under fluorescence examination. Figure la shows
the brochofiberscopic finding of a CIS lesion in
right B6. Thickening of the bifurcation can be seen.
Figure lb shows the LIFE imaging of the same lesion.
Biopsy of this area showed carcinoma in situ (Fig. lc).
Normal fluorescence decreased at the site of CIS.
Metaplasia (moderate or more severe in all cases) was
detected at 25 sites. The sensitivity for metaplasia
detection by conventional bronchoscopy was 28%
(7/25) compared to 96% (24/25) by the LIFE system
(Table II). Figure 2a shows a fight basal bronchus
which seems to be normal on conventional
bronchoscopy. Figure 2b shows the LIFE image of the
same site.A cold spot can be detected in the bifurcation
of B8 and biopsy revealed metaplasia with moderate
atypia (Fig. 2c). In relation to specificity, the LIFE
system had a slightly higher false positive (16/36,
44%) rate than the white light bronchoscopy (14/36,
39%) but the differencewas not statistically significant.
The definition of positive was atypical metaplasia or
cancer.
FIGURE 1C Biopsy revealed squamous cell carcinoma.
RESULTS
Table II shows the biopsy andendoscopy (conventional/
LIFE) results. Of the 77 sites biopsied in 30 subjects,
cancer was detected at 16 sites (invasive
cancer 13, CIS 3). The LIFE diagnosed all 16 ofthem
and had no false negatives. The white light
bronchoscopy diagnosed 15 of the 16 cancers and had
1 false negative (6%). This was a recurrent lesion in
the surgical stump after right upper lobectomy which
seemed to be merely a normal post-operative change
by conventional bronchoscopy.A total of3 CIS lesions
were discovered by both methods but the extent and
margin of the tumor were more clearly observed
DISCUSSION
Sputum cutology examination is often the first method
to detect central type early cancer or metaplasia, but
we sometimes fail to localize the lesion. Such lesions
are so thin that they do not show endoscopically-
visible mucosal changes [1,4]. The concept of
fluorescence endoscopy depends on the fact that an
abnormal area has different autofluorescence from that
of normal areas. The normal area of the bronchus
shows green autofluorescence when excited by blue
light, but abnormal areas such as cancer or metaplasia
show cold spots due to decreased green auto-
fluorescence [6]. Several investigations have been
performed to prove the possible cause of decreased
autofluorescence: thickened cell layers, decreased
amount offlavin in tissue [9], butno definite conclusion
has yet been obtained. In the present study, the
diagnostic rate for cancerous lesions is almost same by
conventionalbronchoscopy and theLIFE system (Only
one lesion was missed by conventional fiberoptic
bronchoscopy). However the extent ofthe lesion could200 N. IKEDA et al.
FIGURE 2A Right basal bronchus under conventional
bronchoscopy. No abnormality was found.
FIGURE 2B Autofluorescence from normal area was represented
by greert A small cold spot was detected in the center of the
bifurcation
FIGURE 2C Biopsy of this area revealed to be moderately
atypical squamous metaplasia.
easily be evaluatedby theLIFE system, which is helpful
in the preoperative determination of the resection line
or the extent of photoradiation when performing
photodynamic therapy. Certain areas of metaplasia
develop cancer and this theory was confirmed by
experiment in dogs 10]. However endoscopic findings
of metaplasia have not been intensively studied.
Thickening of the bifurcation with a whitish color is
the only endoscopically recognizable sign of
metaplasia. The sensitivity of metaplasia detection by
conventional fiberoptic bronchoscope and LIFE was
28% and 96%, respectively.
Lam, a pioneer ofthis system, reported the sensitivity
to be 40% by white light endoscopy and 91% by
LIFE [7]. Concerning this point, the LIFE system is
useful to estimate the effect of chemopreventive
treatment. A total of 36 normal/inflamed sites existed
in this study. Using the LIFE system, 16 sites were
diagnosed as abnormal. Pathological examination
revealed that 5 sites demonstrated trulynormal histology
and 11 sites demonstrated chronic inflammation. False
positive results due to inflammation (basal cell
hyperplasia, thickened basement membrane) in 11 sites
resulted from autofluorescence being absorbed and
diminished by thickened cell layers. The reason for
false positive result in the remaining 5 normal sites
was not clear. Lam reported that some false positive
auto fluorescence lesions appeared to progress rapidly
after the examination while some false negative CIS
cases regressed spontaneously during follow-up [7]. It
is possible biological behaviormay have some influence
on autofluorescence or endogenous fluoropores.
Our study suggests that fluorescence endoscopy is
useful in the detection of early lung cancer as well as
in the detection of precancerous lesions not detectable
by conventional methods. This method requires no
photosensitizer or some specific contrast. On the
average, the fluorescence examination took another 10
minutes after the standard bronchoscopy procedure so
that this modality couldbe routinely used. Fluorescence
endoscopy should contribute to the detection of early
stage lung cancer and therefore to the improvement of
prognosis of this disease, as well as functioning as a
method to investigate the pathogenesis of pulmonary
disease.EARLY LOCALIZATION OF BRONCHOGENIC CANCEROUS LESIONS WITH LIFE 201
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